Discover open access scientific publications

Corrigendum to ‘Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-Versus Host Disease Guided Multiple DLIs Could Improve Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Refractory/Relapsed Acute Leukemia’ [Biology of Blood and Marrow Transplantation 23/8 (2017) 1311-1319]